 | • レポートコード：QYR2104Z2570 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、巨細胞性動脈炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド療法、アジュバント剤）、用途別市場規模（病院、クリニック、ASC、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・巨細胞性動脈炎治療の市場動向 ・企業の競争状況、市場シェア ・巨細胞性動脈炎治療の種類別市場規模（コルチコステロイド療法、アジュバント剤） ・巨細胞性動脈炎治療の用途別市場規模（病院、クリニック、ASC、その他） ・巨細胞性動脈炎治療の北米市場規模2016-2027（アメリカ、カナダ） ・巨細胞性動脈炎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・巨細胞性動脈炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・巨細胞性動脈炎治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・巨細胞性動脈炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Johns Hopkins Hospital、Fortis Healthcare、American College of Rheumatology、Duke University Health System、Lahey Clinic Foundation） ・結論 |
Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age.
Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin however, current evidences are mixed. In a large epidemiologic study with a 12-year follow-up, there has been synchronous variation in the incidence of giant cell arteritis with epidemics of Mycoplasma pneumoniae, Chlamydia pneumonia and parvovirus B19.
Market Analysis and Insights: Global Giant Cell Arteritis Treatment Market
The global Giant Cell Arteritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Giant Cell Arteritis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Giant Cell Arteritis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Giant Cell Arteritis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Giant Cell Arteritis Treatment market.
Global Giant Cell Arteritis Treatment Scope and Market Size
Giant Cell Arteritis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Giant Cell Arteritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Corticosteroid Therapy
Adjuvant Agents
Segment by Application
Hospitals
Clinics
ASCs
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Johns Hopkins Hospital
Fortis Healthcare
American College of Rheumatology
Duke University Health System
Lahey Clinic Foundation
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Giant Cell Arteritis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroid Therapy
1.2.3 Adjuvant Agents
1.3 Market by Application
1.3.1 Global Giant Cell Arteritis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 ASCs
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Giant Cell Arteritis Treatment Market Perspective (2016-2027)
2.2 Giant Cell Arteritis Treatment Growth Trends by Regions
2.2.1 Giant Cell Arteritis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Giant Cell Arteritis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Giant Cell Arteritis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Giant Cell Arteritis Treatment Industry Dynamic
2.3.1 Giant Cell Arteritis Treatment Market Trends
2.3.2 Giant Cell Arteritis Treatment Market Drivers
2.3.3 Giant Cell Arteritis Treatment Market Challenges
2.3.4 Giant Cell Arteritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Giant Cell Arteritis Treatment Players by Revenue
3.1.1 Global Top Giant Cell Arteritis Treatment Players by Revenue (2016-2021)
3.1.2 Global Giant Cell Arteritis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Giant Cell Arteritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Giant Cell Arteritis Treatment Revenue
3.4 Global Giant Cell Arteritis Treatment Market Concentration Ratio
3.4.1 Global Giant Cell Arteritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Giant Cell Arteritis Treatment Revenue in 2020
3.5 Giant Cell Arteritis Treatment Key Players Head office and Area Served
3.6 Key Players Giant Cell Arteritis Treatment Product Solution and Service
3.7 Date of Enter into Giant Cell Arteritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Giant Cell Arteritis Treatment Breakdown Data by Type
4.1 Global Giant Cell Arteritis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Giant Cell Arteritis Treatment Forecasted Market Size by Type (2022-2027)
5 Giant Cell Arteritis Treatment Breakdown Data by Application
5.1 Global Giant Cell Arteritis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Giant Cell Arteritis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Giant Cell Arteritis Treatment Market Size (2016-2027)
6.2 North America Giant Cell Arteritis Treatment Market Size by Type
6.2.1 North America Giant Cell Arteritis Treatment Market Size by Type (2016-2021)
6.2.2 North America Giant Cell Arteritis Treatment Market Size by Type (2022-2027)
6.2.3 North America Giant Cell Arteritis Treatment Market Size by Type (2016-2027)
6.3 North America Giant Cell Arteritis Treatment Market Size by Application
6.3.1 North America Giant Cell Arteritis Treatment Market Size by Application (2016-2021)
6.3.2 North America Giant Cell Arteritis Treatment Market Size by Application (2022-2027)
6.3.3 North America Giant Cell Arteritis Treatment Market Size by Application (2016-2027)
6.4 North America Giant Cell Arteritis Treatment Market Size by Country
6.4.1 North America Giant Cell Arteritis Treatment Market Size by Country (2016-2021)
6.4.2 North America Giant Cell Arteritis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Giant Cell Arteritis Treatment Market Size (2016-2027)
7.2 Europe Giant Cell Arteritis Treatment Market Size by Type
7.2.1 Europe Giant Cell Arteritis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Giant Cell Arteritis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Giant Cell Arteritis Treatment Market Size by Type (2016-2027)
7.3 Europe Giant Cell Arteritis Treatment Market Size by Application
7.3.1 Europe Giant Cell Arteritis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Giant Cell Arteritis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Giant Cell Arteritis Treatment Market Size by Application (2016-2027)
7.4 Europe Giant Cell Arteritis Treatment Market Size by Country
7.4.1 Europe Giant Cell Arteritis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Giant Cell Arteritis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Giant Cell Arteritis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Giant Cell Arteritis Treatment Market Size by Type
8.2.1 Asia-Pacific Giant Cell Arteritis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Giant Cell Arteritis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Giant Cell Arteritis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Giant Cell Arteritis Treatment Market Size by Application
8.3.1 Asia-Pacific Giant Cell Arteritis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Giant Cell Arteritis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Giant Cell Arteritis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Giant Cell Arteritis Treatment Market Size by Region
8.4.1 Asia-Pacific Giant Cell Arteritis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Giant Cell Arteritis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Giant Cell Arteritis Treatment Market Size (2016-2027)
9.2 Latin America Giant Cell Arteritis Treatment Market Size by Type
9.2.1 Latin America Giant Cell Arteritis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Giant Cell Arteritis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Giant Cell Arteritis Treatment Market Size by Type (2016-2027)
9.3 Latin America Giant Cell Arteritis Treatment Market Size by Application
9.3.1 Latin America Giant Cell Arteritis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Giant Cell Arteritis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Giant Cell Arteritis Treatment Market Size by Application (2016-2027)
9.4 Latin America Giant Cell Arteritis Treatment Market Size by Country
9.4.1 Latin America Giant Cell Arteritis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Giant Cell Arteritis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Giant Cell Arteritis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Giant Cell Arteritis Treatment Market Size by Type
10.2.1 Middle East & Africa Giant Cell Arteritis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Giant Cell Arteritis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Giant Cell Arteritis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Giant Cell Arteritis Treatment Market Size by Application
10.3.1 Middle East & Africa Giant Cell Arteritis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Giant Cell Arteritis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Giant Cell Arteritis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Giant Cell Arteritis Treatment Market Size by Country
10.4.1 Middle East & Africa Giant Cell Arteritis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Giant Cell Arteritis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johns Hopkins Hospital
11.1.1 Johns Hopkins Hospital Company Details
11.1.2 Johns Hopkins Hospital Business Overview
11.1.3 Johns Hopkins Hospital Giant Cell Arteritis Treatment Introduction
11.1.4 Johns Hopkins Hospital Revenue in Giant Cell Arteritis Treatment Business (2016-2021)
11.1.5 Johns Hopkins Hospital Recent Development
11.2 Fortis Healthcare
11.2.1 Fortis Healthcare Company Details
11.2.2 Fortis Healthcare Business Overview
11.2.3 Fortis Healthcare Giant Cell Arteritis Treatment Introduction
11.2.4 Fortis Healthcare Revenue in Giant Cell Arteritis Treatment Business (2016-2021)
11.2.5 Fortis Healthcare Recent Development
11.3 American College of Rheumatology
11.3.1 American College of Rheumatology Company Details
11.3.2 American College of Rheumatology Business Overview
11.3.3 American College of Rheumatology Giant Cell Arteritis Treatment Introduction
11.3.4 American College of Rheumatology Revenue in Giant Cell Arteritis Treatment Business (2016-2021)
11.3.5 American College of Rheumatology Recent Development
11.4 Duke University Health System
11.4.1 Duke University Health System Company Details
11.4.2 Duke University Health System Business Overview
11.4.3 Duke University Health System Giant Cell Arteritis Treatment Introduction
11.4.4 Duke University Health System Revenue in Giant Cell Arteritis Treatment Business (2016-2021)
11.4.5 Duke University Health System Recent Development
11.5 Lahey Clinic Foundation
11.5.1 Lahey Clinic Foundation Company Details
11.5.2 Lahey Clinic Foundation Business Overview
11.5.3 Lahey Clinic Foundation Giant Cell Arteritis Treatment Introduction
11.5.4 Lahey Clinic Foundation Revenue in Giant Cell Arteritis Treatment Business (2016-2021)
11.5.5 Lahey Clinic Foundation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Giant Cell Arteritis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Corticosteroid Therapy
Table 3. Key Players of Adjuvant Agents
Table 4. Global Giant Cell Arteritis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Giant Cell Arteritis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Giant Cell Arteritis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Giant Cell Arteritis Treatment Market Share by Regions (2016-2021)
Table 8. Global Giant Cell Arteritis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Giant Cell Arteritis Treatment Market Share by Regions (2022-2027)
Table 10. Giant Cell Arteritis Treatment Market Trends
Table 11. Giant Cell Arteritis Treatment Market Drivers
Table 12. Giant Cell Arteritis Treatment Market Challenges
Table 13. Giant Cell Arteritis Treatment Market Restraints
Table 14. Global Giant Cell Arteritis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Giant Cell Arteritis Treatment Market Share by Players (2016-2021)
Table 16. Global Top Giant Cell Arteritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Giant Cell Arteritis Treatment as of 2020)
Table 17. Ranking of Global Top Giant Cell Arteritis Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Giant Cell Arteritis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Giant Cell Arteritis Treatment Product Solution and Service
Table 21. Date of Enter into Giant Cell Arteritis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Giant Cell Arteritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Giant Cell Arteritis Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Giant Cell Arteritis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Giant Cell Arteritis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Giant Cell Arteritis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Giant Cell Arteritis Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Giant Cell Arteritis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Giant Cell Arteritis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Giant Cell Arteritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Giant Cell Arteritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Giant Cell Arteritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Giant Cell Arteritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Giant Cell Arteritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Giant Cell Arteritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Giant Cell Arteritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Giant Cell Arteritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Giant Cell Arteritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Giant Cell Arteritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Giant Cell Arteritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Giant Cell Arteritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Giant Cell Arteritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Giant Cell Arteritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Giant Cell Arteritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Giant Cell Arteritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Giant Cell Arteritis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Giant Cell Arteritis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Giant Cell Arteritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Giant Cell Arteritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Giant Cell Arteritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Giant Cell Arteritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Giant Cell Arteritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Giant Cell Arteritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Giant Cell Arteritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Giant Cell Arteritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Giant Cell Arteritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Giant Cell Arteritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Giant Cell Arteritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Giant Cell Arteritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Johns Hopkins Hospital Company Details
Table 62. Johns Hopkins Hospital Business Overview
Table 63. Johns Hopkins Hospital Giant Cell Arteritis Treatment Product
Table 64. Johns Hopkins Hospital Revenue in Giant Cell Arteritis Treatment Business (2016-2021) & (US$ Million)
Table 65. Johns Hopkins Hospital Recent Development
Table 66. Fortis Healthcare Company Details
Table 67. Fortis Healthcare Business Overview
Table 68. Fortis Healthcare Giant Cell Arteritis Treatment Product
Table 69. Fortis Healthcare Revenue in Giant Cell Arteritis Treatment Business (2016-2021) & (US$ Million)
Table 70. Fortis Healthcare Recent Development
Table 71. American College of Rheumatology Company Details
Table 72. American College of Rheumatology Business Overview
Table 73. American College of Rheumatology Giant Cell Arteritis Treatment Product
Table 74. American College of Rheumatology Revenue in Giant Cell Arteritis Treatment Business (2016-2021) & (US$ Million)
Table 75. American College of Rheumatology Recent Development
Table 76. Duke University Health System Company Details
Table 77. Duke University Health System Business Overview
Table 78. Duke University Health System Giant Cell Arteritis Treatment Product
Table 79. Duke University Health System Revenue in Giant Cell Arteritis Treatment Business (2016-2021) & (US$ Million)
Table 80. Duke University Health System Recent Development
Table 81. Lahey Clinic Foundation Company Details
Table 82. Lahey Clinic Foundation Business Overview
Table 83. Lahey Clinic Foundation Giant Cell Arteritis Treatment Product
Table 84. Lahey Clinic Foundation Revenue in Giant Cell Arteritis Treatment Business (2016-2021) & (US$ Million)
Table 85. Lahey Clinic Foundation Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Giant Cell Arteritis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Corticosteroid Therapy Features
Figure 3. Adjuvant Agents Features
Figure 4. Global Giant Cell Arteritis Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. ASCs Case Studies
Figure 8. Others Case Studies
Figure 9. Giant Cell Arteritis Treatment Report Years Considered
Figure 10. Global Giant Cell Arteritis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Giant Cell Arteritis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Giant Cell Arteritis Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Giant Cell Arteritis Treatment Market Share by Regions (2022-2027)
Figure 14. Global Giant Cell Arteritis Treatment Market Share by Players in 2020
Figure 15. Global Top Giant Cell Arteritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Giant Cell Arteritis Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Giant Cell Arteritis Treatment Revenue in 2020
Figure 17. Global Giant Cell Arteritis Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Giant Cell Arteritis Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Giant Cell Arteritis Treatment Market Share by Type (2016-2027)
Figure 21. North America Giant Cell Arteritis Treatment Market Share by Application (2016-2027)
Figure 22. North America Giant Cell Arteritis Treatment Market Share by Country (2016-2027)
Figure 23. United States Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Giant Cell Arteritis Treatment Market Share by Type (2016-2027)
Figure 27. Europe Giant Cell Arteritis Treatment Market Share by Application (2016-2027)
Figure 28. Europe Giant Cell Arteritis Treatment Market Share by Country (2016-2027)
Figure 29. Germany Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Giant Cell Arteritis Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Giant Cell Arteritis Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Giant Cell Arteritis Treatment Market Share by Region (2016-2027)
Figure 39. China Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Giant Cell Arteritis Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Giant Cell Arteritis Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Giant Cell Arteritis Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Giant Cell Arteritis Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Giant Cell Arteritis Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Giant Cell Arteritis Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Giant Cell Arteritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Johns Hopkins Hospital Revenue Growth Rate in Giant Cell Arteritis Treatment Business (2016-2021)
Figure 59. Fortis Healthcare Revenue Growth Rate in Giant Cell Arteritis Treatment Business (2016-2021)
Figure 60. American College of Rheumatology Revenue Growth Rate in Giant Cell Arteritis Treatment Business (2016-2021)
Figure 61. Duke University Health System Revenue Growth Rate in Giant Cell Arteritis Treatment Business (2016-2021)
Figure 62. Lahey Clinic Foundation Revenue Growth Rate in Giant Cell Arteritis Treatment Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界の基底細胞がん治療市場規模・現状・予測（2021年-2027年） Basal cell carcinoma (BCC) is the most common type of skin cancer. It’s also the most commonly diagnosed cancer in the United States. Every year, millions of people learn that they have BCC. Basal cell carcinoma that is superficial and doesn't extend very far into the skin may be treated with creams…- 世界の基底細胞皮膚がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Basal Cell Skin Cancer Treatment Market The global Basal Cell Skin Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
- 世界の基底細胞皮膚がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Basal Cell Skin Cancer Treatment Market The global Basal Cell Skin Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
- 世界の球形細胞白質ジストロフィー治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Globoid Cell Leukodystrophy Treatment Market The global Globoid Cell Leukodystrophy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and…
- 世界の形質細胞新生物治療市場規模・現状・予測（2021年-2027年） Plasma cell neoplasms are diseases in which the body makes too many plasma cells. The plasma cells also make an antibody protein, called M protein, that is not needed by the body and does not help fight infection. These antibody proteins build up in the bone marrow and can cause the blood to thicken…